BioMarin Pharmaceutical Inc (BMRN)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$60.88
Buy
$61.90
$9.20 (+17.71%)
Prices updated at 19 Dec 2025, 22:04 EST
| Prices minimum 15 mins delay
Prices in USD
Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 79.67 |
| 2023 | 78.01 |
| 2022 | 76.00 |
| 2021 | 74.52 |
| 2020 | 71.82 |
| 2019 | 78.91 |
| 2018 | 78.86 |
| 2017 | 81.59 |
| 2016 | 81.23 |
| 2015 | 82.92 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 3.31 |
| 2024 | 4.60 |
| 2023 | 7.97 |
| 2022 | 9.79 |
| 2021 | 8.72 |
| 2020 | 9.00 |
| 2019 | 9.43 |
| 2018 | 10.04 |
| 2017 | 12.33 |
| 2016 | 12.96 |
| 2015 | 18.38 |
Price/Forward earnings (YTD)
10.45
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | 6.17 |
| 2023 | 2.54 |
| 2022 | 2.29 |
| 2021 | -1.08 |
| 2020 | 16.21 |
| 2019 | -0.52 |
| 2018 | -1.70 |
| 2017 | -2.70 |
| 2016 | -16.26 |
| 2015 | -5.54 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.24 |
| 2023 | 1.38 |
| 2022 | 1.38 |
| 2021 | 1.41 |
| 2020 | 1.42 |
| 2019 | 1.50 |
| 2018 | 1.49 |
| 2017 | 1.65 |
| 2016 | 1.45 |
| 2015 | 1.55 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
